Amphastar P (AMPH)

Net profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	137,545	135,291	101,943	93,165	91,386	77,233	90,907	81,328	62,116	36,083	10,454	2,495	1,403	6,650	4,041	52,020	48,939	51,832	52,911	2,271
Revenue (ttm)	US$ in thousands	644,395	601,313	540,886	518,641	498,987	484,851	476,920	455,116	437,768	412,802	384,035	368,178	349,846	337,308	334,014	327,255	322,357	328,664	324,070	316,063
Net profit margin		21.34%	22.50%	18.85%	17.96%	18.31%	15.93%	19.06%	17.87%	14.19%	8.74%	2.72%	0.68%	0.40%	1.97%	1.21%	15.90%	15.18%	15.77%	16.33%	0.72%

December 31, 2023 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $137,545K ÷ $644,395K
= 21.34%

Amphastar Pharmaceuticals Inc's net profit margin has shown fluctuations over the past eight quarters. The net profit margin ranged from a low of 15.93% in Q3 2022 to a high of 22.50% in Q3 2023. On average, the net profit margin for the periods analyzed was approximately 19.05%. It is worth noting that the company's net profit margin has generally been trending upwards since Q3 2022, indicating an improvement in profitability over this period. The latest reported net profit margin of 21.34% in Q4 2023 suggests that the company has been effectively managing its expenses and generating profits relative to its revenue. Investors and stakeholders may view the upward trend in net profit margin favorably as an indication of the company's financial health and operational efficiency.